APA (7th ed.) Citation

B, B., K, K., M, K., A, S., & A, C. (2025). Doxorubicin or Epirubicin Versus Liposomal Doxorubicin Therapy-Differences in Cardiotoxicity. Cardiovascular toxicology, 25(2), 248. https://doi.org/10.1007/s12012-024-09952-4

Chicago Style (17th ed.) Citation

B, Buchalska, Kamińska K, Kowara M, Sobiborowicz-Sadowska A, and Cudnoch-Jędrzejewska A. "Doxorubicin or Epirubicin Versus Liposomal Doxorubicin Therapy-Differences in Cardiotoxicity." Cardiovascular Toxicology 25, no. 2 (2025): 248. https://doi.org/10.1007/s12012-024-09952-4.

MLA (9th ed.) Citation

B, Buchalska, et al. "Doxorubicin or Epirubicin Versus Liposomal Doxorubicin Therapy-Differences in Cardiotoxicity." Cardiovascular Toxicology, vol. 25, no. 2, 2025, p. 248, https://doi.org/10.1007/s12012-024-09952-4.